| Literature DB >> 33278874 |
Daphne C Erkelens1, Frans H Rutten2, Loes T Wouters2, L Servaas Dolmans2, Esther de Groot2, Roger A Damoiseaux2, Dorien L Zwart2.
Abstract
BACKGROUND: The Netherlands Triage Standard (NTS) is a widely used decision support tool for telephone triage at Dutch out-of-hours primary care services (OHS-PC), which, however, has never been validated against clinical outcomes. We aimed to determine the accuracy of the NTS urgency allocation for patients with neurological symptoms suggestive of a transient ischaemic attack (TIA) or stroke, with the clinical outcomes TIA, stroke, and other (neurologic) life-threatening events (LTEs) as the reference.Entities:
Year: 2020 PMID: 33278874 PMCID: PMC7719259 DOI: 10.1186/s12875-020-01334-3
Source DB: PubMed Journal: BMC Fam Pract ISSN: 1471-2296 Impact factor: 2.497
NTS levels of urgency
| NTS Urgency level | Definition | Response time | Medical help |
|---|---|---|---|
| U0 – Resuscitation | Loss of vital functions | Immediately | Ambulance |
| U1 – Life threatening | Unstable vital functions | Within 15 min | Ambulance |
| U2 – Emergent | Vital functions in danger or organ damage | As soon as possible, within 1 h | Home visit by GP or appointment at OHS-PC |
| U3 – Urgent | Possible risk of damage, human reasons | A few hours (< 3 h) | Home visit by GP or appointment at OHS-PC |
| U4 – Non-urgent | Marginal risk of damage | 24 h | Appointment at OHS-PC or telephone advice |
| U5 – Advice | No risk of damage | Advice, no time related | Telephone advice |
GP General Practitioner, NTS Netherlands Triage Standard, OHS-PC Out-Of-Hours Services in Primary Care
Fig. 1Flowchart study population
Characteristics of 1269 patients with symptoms suggestive of TIA or stroke calling the OHS-PC
| High NTS urgency | Low NTS urgency | ||
|---|---|---|---|
| Median age in years (IQR) | 73.5 (59.0–84.0) | 69.0 (55.0–82.0) | < 0.001 |
| Female sex | 441 (57.3) | 281 (56.3) | 0.736 |
| Family history of CVD ( | 14 (82.4) | 13 (68.4) | 0.451& |
| Cardiovascular disease ( | 421 (79.1) | 259 (74.0) | 0.076 |
| TIA ( | 116 (29.7) | 60 (24.4) | 0.147 |
| Stroke ( | 113 (28.9) | 60 (24.4) | 0.213 |
| Coronary artery disease ( | 36 (20.6) | 18 (14.1) | 0.144 |
| Arrhythmia ( | 32 (19.5) | 25 (19.5) | 0.997 |
| Valvular heart disease ( | 16 (10.9) | 9 (8.0) | 0.429 |
| Heart failure ( | 14 (9.5) | 10 (8.7) | 0.831 |
| Epilepsy ( | 15 (11.6) | 9 (8.7) | 0.458 |
| Migraine ( | 17 (27.0) | 14 (35.9) | 0.342 |
| 14 (9.5) | 10 (8.7) | 0.831 | |
| Hypertension ( | 121 (50.2) | 85 (47.2) | 0.544 |
| Hypercholesterolemia or use of statins ( | 95 (43.0) | 75 (43.1) | 0.981 |
| Diabetes mellitus ( | 87 (36.7) | 63 (35.0) | 0.719 |
| Antithrombotics ( | 290 (48.7) | 149 (43.4) | 0.123 |
| Other cardiovascular medication ( | 253 (57.55) | 178 (54.9) | 0.480 |
| Median call duration in min:sec (IQR) | 06:32 (04:43–08:54) | 07:59 (05:54–10:50) | < 0.001 |
| Median time for caller’s introduction in min:sec (IQR) | 00:19 (00:12–00:27) | 00:20 (00:13–00:29) | 0.189 |
| Initial call by someone else than the patient | 621 (80.6) | 342 (68.5) | < 0.001 |
| Triage nurse consulted the general practitioner | 449 (58.3) | 305 (61.1) | 0.319 |
| Neurological deficit | 587 (76.2) | 220 (44.1) | < 0.001 |
| Dizziness | 21 (2.7) | 87 (17.4) | < 0.001 |
| Headache | 23 (3.0) | 28 (5.6) | 0.020 |
| Odd behavior | 21 (2.7) | 18 (3.6) | 0.375 |
| Syncope | 20 (2.6) | 9 (1.8) | 0.355 |
| Vision problem | 2 (0.3) | 25 (5.0) | < 0.001& |
| Leg or arm problem | 11 (1.4) | 34 (6.8) | < 0.001 |
| Other^ | 85 (11.0) | 78 (15.6) | 0.017 |
| Decreased or loss of consciousness ( | 49 (7.4) | 21 (4.8) | 0.081 |
| Face drooping ( | 258 (54.3) | 93 (39.1) | < 0.001 |
| Arm weakness ( | 254 (51.0) | 77 (28.1) | < 0.001 |
| Leg weakness ( | 201 (49.0) | 85 (35.0) | < 0.001 |
| Sensory disturbances ( | 192 (89.7) | 150 (93.2) | 0.243 |
| Communication problem in general ( | 413 (80.8) | 187 (72.5) | 0.008 |
| Dysarthria ( | 181 (65.1) | 76 (55.1) | 0.047 |
| Dysphasia ( | 163 (59.1) | 72 (50.3) | 0.089 |
| Vision problem in general ( | 68 (78.2) | 82 (84.5) | 0.266 |
| Blurry vision ( | 27 (77.1) | 27 (69.2) | 0.444 |
| Diplopia ( | 14 (63.6) | 23 (44.2) | 0.127 |
| Reduced vision ( | 15 (53.6) | 22 (64.7) | 0.374 |
| Headache ( | 147 (57.0) | 140 (58.6) | 0.718 |
| Loss of balance/motor coordination (ataxia) ( | 130 (86.1) | 66 (77.6) | 0.097 |
| Dizziness ( | 120 (82.2) | 143 (86.1) | 0.338 |
| Seizure ( | 4 (66.7) | 3 (60.0) | 0.819& |
| Short term memory loss ( | 33 (76.7) | 21 (84.0) | 0.476 |
| Shortness of breath ( | 62 (24.4) | 25 (16.8) | 0.072 |
| Sweating ( | 47 (36.7) | 45 (56.3) | 0.006 |
| Nausea or vomiting ( | 84 (61.8) | 94 (53.7) | 0.155 |
| Pallor ( | 54 (32.7) | 27 (30.0) | 0.655 |
| Ashen skin ( | 18 (14.1) | 12 (17.1) | 0.563 |
| (Feeling of nearly) fainting ( | 57 (8.6) | 41 (9.3) | 0.680 |
| Onset of symptoms: | |||
| Per acute (seconds) ( | 52 (44.1) | 56 (60.2) | 0.020 |
| Acute (minutes) ( | 46 (39.0) | 23 (24.7) | 0.028 |
| Gradually (hours) ( | 20 (16.9) | 14 (15.1) | 0.710 |
| Duration of symptoms ≤4.5 h ( | 381 (61.4) | 203 (55.6) | 0.077 |
| Symptoms still present at time of calling ( | 716 (93.4) | 438 (89.9) | 0.030 |
| Caller expresses concern ( | 334 (90.3) | 248 (96.1) | 0.006 |
| Patient never experienced similar symptoms before ( | 104 (49.8) | 68 (42.8) | 0.183 |
| Recognition of symptoms: | |||
| TIA ( | 40 (19.1) | 26 (16.4) | 0.490 |
| Stroke ( | 25 (12.0) | 16 (10.1) | 0.566 |
N number (first column) stands for number of patients in which information on the variable of that row is known
NTS Netherlands Triage Standard, IQR interquartile range, CVD Cardiovascular disease, TIA Transient ischaemic attack
High NTS urgency: U1 and U2; Low NTS urgency: U3, U4 and U5
*Concerns all cardiovascular medication with the exception of antithrombotics; #Pearson Chi Square Test for categorical variables and Mann-Whitney U Test for not normally distributed continuous variables; &Fisher’s Exact Test for categorical variables; ^Amongst others: vomiting, dyspnea, neck symptoms, insult, disability problems (‘D from ABCD’)
Final diagnoses of 1269 patients who called the OHS-PC for symptoms suggestive of TIA/stroke
| High NTS urgency | Low NTS urgency | ||
|---|---|---|---|
| TIA/minor stroke | 276 (35.8) | 158 (31.7) | 0.125 |
| Major ischaemic or haemorrhagic strokea | 149 (19.4) | 52 (10.4) | < 0.001 |
| Other life threatening events (LTEs)b: | 45 (5.8) | 16 (3.2) | 0.032 |
| - Intracranial haemorrhagec | 17 (37.8) | 7 (43.8) | 0.674 |
| Migraine: | 21 (2.7) | 21 (4.2) | 0.150 |
| - With aura | 9 (42.9) | 7 (33.3) | 0.525 |
| Epilepsy | 17 (2.2) | 6 (1.2) | 0.190 |
| Syncope | 18 (2.3) | 12 (2.4) | 0.939 |
| Brain tumor | 13 (1.7) | 2 (0.4) | 0.059^ |
| Peripheral vestibular syndromes: | 22 (2.9) | 42 (8.4) | < 0.001 |
| - Benign paroxysmal positional vertigo | 10 (45.5) | 11 (26.2) | 0.119 |
| - Meniere disease | 1 (4.5) | 1 (2.4) | 0.999^ |
| - Vestibular neuritis | 0 (0.0) | 5 (11.9) | 0.155^ |
| Peripheral nerve problem: | 75 (9.7) | 47 (9.4) | 0.850 |
| - Bell’s palsy | 22 (29.3) | 13 (27.7) | 0.842 |
| - Facial nerve palsy other than Bell’s palsy | 53 (70.7) | 34 (72.3) | 0.842 |
| Psychogenic syndromes | 27 (3.5) | 26 (5.2) | 0.138 |
| Other non-urgent diagnosesd | 107 (13.9) | 117 (23.4) | < 0.001 |
High NTS urgency: U1 and U2; Low NTS urgency: U3, U4 and U5. aIncluding lacunar infarction and stroke not otherwise specified; bAmongst others sepsis, acute coronary syndrome, meningitis, herpes encephalitis, coma, severe anemia due to gastrointestinal bleeding, hypoglycaemia, acute pulmonary embolism; cIncluding subarachnoid haemorrhage; dAmongst others guillain barre, multiple sclerosis, alcohol intoxication; ^Fisher’s Exact Test
Fig. 2NTS urgency adjustments of 1269 patients with symptoms suggestive of TIA/minor stroke. This Figure does not show differences within the high and low urgency groups, for the differences within all urgency groups (U1-U5) see supplementary data Table S2
Accuracy of adequate NTS urgency and final urgency allocation for detecting TIA/stroke/other LTEs
| Adequate NTS urgency allocation | Adequate final urgency allocation | ||
|---|---|---|---|
| Sensitivity | 0.71 (0.68–0.75) | 0.86 (0.84–0.89) | |
| Specificity | 0.46 (0.42–0.50) | 0.38 (0.34–0.42) | |
| Positive predictive value | 0.41 (0.38–0.43) | 0.42 (0.40–0.44) | |
| Negative predictive value | 0.75 (0.72–0.78) | 0.84 (0.81–0.87) | |
| Sensitivity | 0.74 (0.61–0.84) | 0.82 (0.70–0.91) | |
| Specificity | 0.40 (0.37–0.43) | 0.32 (0.30–0.35) | |
| Positive predictive value | 0.06 (0.05–0.07) | 0.06 (0.05–0.06) | |
| Negative predictive value | 0.97 (0.95–0.98) | 0.97 (0.95–0.98) | |
| Sensitivity | 0.72 (0.68–0.75) | 0.86 (0.83–0.89) | |
| Specificity | 0.48 (0.43–0.52) | 0.40 (0.36–0.44) | |
| Positive predictive value | 0.62 (0.60–0.64) | 0.63 (0.62–0.65) | |
| Negative predictive value | 0.58 (0.54–0.62) | 0.70 (0.66–0.74) | |
aPrevalence TIA/minor stroke 34.2% and prevalence major stroke 15.8%; bPrevalence other LTEs 4.8%; cFor TIA/minor stroke urgencies U1, U2 and U3 were all considered adequate, for major stroke and other LTEs urgencies U1 and U2 were considered adequate